In COPD patients, inhibition of IKK2 selectively inhibits IK-B phosphorylation, preventing NFkB stimulation, including its nuclear translocation and the inflammatory reaction, but it was observed that IKK2-deficient mice were not alive. Here, NFKB1 is linked to chronic obstructive pulmonary disease.